Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Weekly Wrap 10 November

Sophia Mavridis
November 10, 2023

Morning Bell 10 November

Sam Kanaan
November 10, 2023

Morning Bell 9 November

Sophia Mavridis
November 9, 2023

Morning Bell 8 November

Sam Kanaan
November 8, 2023

Morning Bell 7 November

Sophia Mavridis
November 7, 2023

Morning Bell 6 November

Sam Kanaan
November 6, 2023

Weekly Wrap 3 November

Grady Wulff
November 3, 2023

Morning Bell 3 November

Sam Kanaan
November 3, 2023

Morning Bell 2 November

Grady Wulff
November 2, 2023

Morning Bell 1 November

Sam Kanaan
November 1, 2023

Morning Bell 31 October

Sam Kanaan
October 31, 2023

Morning Bell 30 October

Grady Wulff
October 30, 2023